Literature DB >> 8781974

Glycolipids and myelin proteins in human oligodendrogliomas.

C C Sung1, R Collins, J Li, D K Pearl, S W Coons, B W Scheithauer, P C Johnson, A J Yates.   

Abstract

We studied myelin proteins and glycolipids in 24 human oligodendrogliomas (16 pure, eight mixed), including two grade I, 13 grade II, five grade III, and four grade IV. Tumours with a 1b ganglioside content (GD1b, GT1b and GQ1b) over 30% of total gangliosides occur more frequently in the WHO grade I and II (47%) and grade III (40%) than in the grade IV (25%) group; there was no difference in the amounts of total ganglioside or individual gangliosides between pure and mixed oligodendrogliomas. The presence of 6'-LM1 correlated with higher grades of tumours (chi 2 P approximately 0.02); however, 3'-LM1 and total neolacto-series gangliosides did not correlated with grade. Immunohistochemical studies of oligodendrocyte and myelin markers (GalCer, sulfatide, 2',3' -cyclic nucleotide phosphodiesterase, myelin basic protein and proteolipid protein) using specific antibodies showed only a very small proportion of tumour cells staining. These data do not support the hypothesis that tumours classified as oligodendrogliomas are derived from mature oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781974     DOI: 10.1007/bf00731476

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  31 in total

Review 1.  Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.

Authors:  S Hakomori
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

2.  GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA.

Authors:  S J Rabin; I Mocchetti
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

3.  Antigenic expression by cells derived from human gliomas does not correlate with morphological classification.

Authors:  P G Kennedy; B A Watkins; D G Thomas; M D Noble
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Sep-Oct       Impact factor: 8.090

4.  Ganglioside GM3 inhibits the proliferation of cultured keratinocytes.

Authors:  A S Paller; S L Arnsmeier; M Alvarez-Franco; E G Bremer
Journal:  J Invest Dermatol       Date:  1993-06       Impact factor: 8.551

5.  Glial fibrillary acidic protein (GFAP) in oligodendrogliomas: a reflection of transient GFAP expression by immature oligodendroglia.

Authors:  V Jagadha; W C Halliday; L E Becker
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

6.  Expression of glial fibrillary acidic protein in immature oligodendroglia.

Authors:  B H Choi; R C Kim
Journal:  Science       Date:  1984-01-27       Impact factor: 47.728

7.  Correlation of ganglioside patterns of primary brain tumors with survival.

Authors:  C C Sung; D K Pearl; S W Coons; B W Scheithauer; P C Johnson; M Zheng; A J Yates
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

8.  Mixed oligodendroglioma and astrocytoma: fine structural and immunohistochemical studies of four cases.

Authors:  H Kamitani; H Masuzawa; J Sato; I Kanazawa
Journal:  J Neurol Sci       Date:  1988-02       Impact factor: 3.181

9.  Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.

Authors:  C C Sung; D K Pearl; S W Coons; B W Scheithauer; P C Johnson; A J Yates
Journal:  Cancer       Date:  1994-12-01       Impact factor: 6.860

10.  Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 cells.

Authors:  J Van Brocklyn; E G Bremer; A J Yates
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

View more
  10 in total

1.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 2.  The cellular origin for malignant glioma and prospects for clinical advancements.

Authors:  Hui Zong; Roel G W Verhaak; Peter Canoll
Journal:  Expert Rev Mol Diagn       Date:  2012-05       Impact factor: 5.225

3.  Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.

Authors:  Q R Lu; J K Park; E Noll; J A Chan; J Alberta; D Yuk; M G Alzamora; D N Louis; C D Stiles; D H Rowitch; P M Black
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

4.  Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.

Authors:  Y Shoshan; A Nishiyama; A Chang; S Mörk; G H Barnett; J K Cowell; B D Trapp; S M Staugaitis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.

Authors:  P Dzięgiel; T Owczarek; E Plazuk; A Gomułkiewicz; M Majchrzak; M Podhorska-Okołów; K Driouch; R Lidereau; M Ugorski
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

6.  Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

Authors:  Hideaki Yokoo; Sumihito Nobusawa; Hirohide Takebayashi; Kazuhiro Ikenaka; Koji Isoda; Makoto Kamiya; Atsushi Sasaki; Junko Hirato; Yoichi Nakazato
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Authors:  Hiroaki Takeuchi; Toshihiko Kubota; Ryuhei Kitai; Ken Matsuda; Norichika Hashimoto; Kazufumi Sato
Journal:  J Neurooncol       Date:  2008-09-10       Impact factor: 4.130

8.  Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.

Authors:  Tomasz B Owczarek; Jarosław Suchanski; Bartosz Pula; Alicja M Kmiecik; Marek Chadalski; Aleksandra Jethon; Piotr Dziegiel; Maciej Ugorski
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.

Authors:  Hidehiro Takei; Subashini T Yogeswaren; Kwong-Kwok Wong; Vidya Mehta; Murali Chintagumpala; Robert C Dauser; Ching C Lau; Adekunle M Adesina
Journal:  J Neurooncol       Date:  2007-08-10       Impact factor: 4.506

Review 10.  Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease.

Authors:  Safoura Reza; Maciej Ugorski; Jarosław Suchański
Journal:  Glycobiology       Date:  2021-12-18       Impact factor: 4.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.